Crop Life ScienceNSE:CLSL 58 Current Ratio is 1.55 as of Mar. 2026, which is 3% above its 10-year median of 1.51. GuruFocus rates NSE:CLSL with a GF Score™ of 58/100 and a GF Value™ of ₹54.99 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 260 Agriculture companies, Crop Life Science ranks worse than 50.38% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Crop Life Science's current ratio for the quarter that ended in Mar. 2026 was 1.55.
Crop Life Science has a current ratio of 1.55. It generally indicates good short-term financial strength.
The historical rank and industry rank for Crop Life Science's Current Ratio or its related term are showing as below:
NSE:CLSL'
s Current Ratio Range Over the Past 10 Years
Min: 1.44 Med: 1.51 Max: 1.56
Current: 1.55
During the past 7 years, Crop Life Science's highest Current Ratio was 1.56. The lowest was 1.44. And the median was 1.51.
NSE:CLSL's Current Ratio is ranked worse than 50.38% of 260
companies
in the Agriculture industry
Industry Median: 1.56
vs NSE:CLSL: 1.55
Crop Life Science (NSE:CLSL) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Crop Life Science Current Ratio Related Terms
Crop Life Science Current Ratio Historical Data
* Premium members only.
The historical data trend for Crop Life Science's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CLSL vs CTVA, CF, MOS: Current Ratio Comparison
For the Agricultural Inputs subindustry, Crop Life Science's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Crop Life Science Current Ratio vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Crop Life Science's Current Ratio distribution charts can be found below:
* The bar in red indicates where Crop Life Science's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Crop Life Science (NSE:CLSL) has a Current Ratio of 1.55 as of Mar. 2026. This is near median its historical median of 1.51. Over the past decade, Crop Life Science's Current Ratio has ranged from 1.44 to 1.56. According to the industry distribution chart, Crop Life Science ranks #131 out of 260 companies in the Agriculture industry, placing it in the top 50.4%.
Is Crop Life Science's Current Ratio too high?
Crop Life Science's current Current Ratio of 1.55 is near median its 10-year median of 1.51. Over the past 10 years, this metric has ranged from a low of 1.44 to a high of 1.56. The Agriculture industry median Current Ratio is 1.56. Crop Life Science's value of 1.55 is 0.6% below this industry median. Based on the distribution chart, Crop Life Science ranks #131 out of 260 companies in the Agriculture industry, which is below the industry midpoint. Overall, Crop Life Science has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's Current Ratio compare to CTVA and CF?
According to the Agriculture industry distribution chart, Crop Life Science ranks #131 out of 260 companies for Current Ratio. This places Crop Life Science in the lower half of its industry. The industry median Current Ratio is 1.56. Crop Life Science's value of 1.55 is 0.6% below this benchmark. Historically, Crop Life Science's own Current Ratio has ranged from 1.44 to 1.56 over the past decade. While the company's 10-year median is 1.51 vs. the industry median of 1.56, Crop Life Science has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for an Agriculture company?
The median Current Ratio among Agriculture companies is 1.56, based on 260 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Crop Life Science's current Current Ratio of 1.55 is 0.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Agriculture industry, the median Current Ratio is 1.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Crop Life Science's current Current Ratio is 1.55, which is near median its own 10-year median of 1.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹54.99, compared to a current price of ₹43.00 — trading 21.8% below its estimated fair value. The current Current Ratio is 1.55, which is near median its 10-year median of 1.51 and 0.6% below the Agriculture industry median of 1.56. Crop Life Science's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current Current Ratio is 1.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Crop Life Science (NSE:CLSL) Overvalued in 2026?
Based on GuruFocus' analysis, Crop Life Science stock appears to be undervalued.
The current stock price of ₹43.00 is trading 21.8% below its estimated GF Value™ of ₹54.99.
GuruFocus considers Crop Life Science to be Modestly Undervalued.
Key valuation signals for NSE:CLSL:
Current Ratio: 1.55 (near median its 10-year median of 1.51)
GF Value™: ₹54.99 vs. price of ₹43.00 (21.8% below fair value)
Industry Position: 0.6% below the Agriculture median (#131 of 260)
No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
58GF Score
Get the complete analysis for NSE:CLSL
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CLSL has been successfully added to your 
